Syros Pharmaceuticals (SYRS): Deerfield Management Discloses Position

Page 14 of 14

Page 14 of 14 – SEC Filing
Exhibit B
Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

Follow Syros Pharmaceuticals Inc.

Page 14 of 14